Total medical devices industry M&A deals in Q4 2020 worth $11.67bn were announced in the US, according to GlobalData’s deals database.
The value marked a decrease of 75.2% over the previous quarter and a drop of 11.4% when compared with the last four-quarter average of $13.18bn.
The US held an 89.1% share of the global medical devices industry M&A deal value that totalled $13.1bn in Q4 2020. 
In terms of deal activity, the US recorded 65 deals during Q4 2020, marking a rise of 6.6% over the previous quarter and a rise of 18.2% over the last four-quarter average.
The US medical devices industry M&A deals in Q4 2020: Top deals
The top five medical devices industry M&A deals accounted for 79.7% of the overall value during Q4 2020.
The combined value of the top five medical devices M&A deals stood at $9.3bn, against the overall value of $11.67bn recorded for the quarter.
The top five medical devices industry deals of Q4 2020 tracked by GlobalData were:
- Koninklijke Philips’ $2.8bn acquisition of BioTelemetry
- The $2.15bn acquisition of Thrive Earlier Detection by Exact Sciences
- AdaptHealth’s $2bn acquisition of AeroCare
- The $1.5bn acquisition of Butterfly Network by Longview Acquisition
- Steris’ acquisition of Key Surgical for $850m.
For more information
To gain access to our latest press releases: GlobalData Media Centre
Analysts are available for comment. Please contact the GlobalData Press Office:
EMEA & Americas: +44 207 936 6400
Asia-Pacific: +91 40 6616 6809
Email: pr@globaldata.com
For expert analysis on developments in your industry, please connect with us on:
GlobalData | LinkedIn | Twitter
Notes to Editors
This analysis considers only announced and completed deals from the GlobalData financial deals database and exclude all terminated and rumored deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
About GlobalData 4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis, and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, technology, energy, financial and professional services sectors.
